Company intelligence / Profile preview
Milestone Pharmaceuticals
Saint-Laurent, Quebec, Canadamilestonepharma.com ↗
- Ownership
- Public · MIST
- Development stage
- Phase 3
01
Overview
Etripamil nasal spray has completed a robust Phase 3 clinical program in PSVT and a Phase 2 trial in AFib-RVR. The New Drug Application for CARDAMYST™ (etripamil) was accepted by the FDA with a PDUFA goal date of March 27, 2025. No clinical safety or efficacy concerns were raised by the FDA; current regulatory focus relates to manufacturing issues. If approved, it will be the first self-administered therapy for rapid termination of PSVT episodes outside medical settings
- Therapeutic areas
- Cardiovascular
- Modalities
- Small moleculeCalcium channel blocker (small molecule)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Corxel partnership/licensing agreement for China market expansion
04
Financials
- Market cap
- $130.7M
- Total revenue
- $559K
- Enterprise value
- $102.1M
Beyond the preview
Go deeper on Milestone Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Milestone Pharmaceuticals.